Trial Profile
Latanoprost versus diclofenac in type 1 diabetes mellitus and mild retinopathy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Mar 2013
Price :
$35
*
At a glance
- Drugs Diclofenac (Primary) ; Latanoprost (Primary)
- Indications Diabetic retinopathy
- Focus Pharmacodynamics
- 22 Mar 2013 New trial record